Kolly, Carine
Novartis (Switzerland) · Novartis Institutes for BioMedical Research
2 papers on CoChat
Most cited papers
- Verified
The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease
Neumann, U., Ufer, M., Jacobson, L. H., Rouzade‐Dominguez, M., Huledal, G., Kolly, C., Lüönd, R. M., Machauer, R., Veenstra, S. J., Hurth, K., et al. (2018) · EMBO Molecular Medicine
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 177
- Verified
Proliferative and Non-Proliferative Lesions of the Rat and Mouse Integument
Mecklenburg, L., Kusewitt, D., Kolly, C., Treumann, S., Adams, E. T., Diegel, K., Yamate, J., Kaufmann, W., Müller, S., Danilenko, D., et al. (2013) · Journal of Toxicologic Pathology
Immunotoxicology and immune responsesCarcinogens and Genotoxicity Assessment
Cited by 81
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free